The safety and effectiveness of genetically corrected iPSCs derived from β-thalassaemia patients in nonmyeloablative β-thalassaemic mice

BACKGROUND: β-Thalassaemia is a clinically common cause of hereditary haemolytic anaemia stemming from mutations in important functional regions of the β-globin gene. The rapid development of gene editing technology and induced pluripotent stem cell (iPSC)-derived haematopoietic stem cell (HSC) tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Xian, Yexing, Xie, Yingjun, Song, Bing, Ou, Zhanhui, Ouyang, Shuming, Xie, Yuhuan, Yang, Yi, Xiong, Zeyu, Li, Haoxian, Sun, Xiaofang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367314/
https://www.ncbi.nlm.nih.gov/pubmed/32678022
http://dx.doi.org/10.1186/s13287-020-01765-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367314/
https://www.ncbi.nlm.nih.gov/pubmed/32678022
http://dx.doi.org/10.1186/s13287-020-01765-w

Ejemplares similares